BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28677162)

  • 1. The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study.
    Berntsson J; Svensson MC; Leandersson K; Nodin B; Micke P; Larsson AH; Eberhard J; Jirström K
    Int J Cancer; 2017 Oct; 141(8):1654-1666. PubMed ID: 28677162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.
    Nosho K; Baba Y; Tanaka N; Shima K; Hayashi M; Meyerhardt JA; Giovannucci E; Dranoff G; Fuchs CS; Ogino S
    J Pathol; 2010 Dec; 222(4):350-66. PubMed ID: 20927778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer.
    Hanke T; Melling N; Simon R; Sauter G; Bokemeyer C; Lebok P; Terracciano LM; Izbicki JR; Marx AH
    Int J Clin Exp Pathol; 2015; 8(7):8227-35. PubMed ID: 26339391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion of BLIMP-1
    Ward-Hartstonge KA; McCall JL; McCulloch TR; Kamps AK; Girardin A; Cretney E; Munro FM; Kemp RA
    Cancer Immunol Immunother; 2017 Apr; 66(4):515-522. PubMed ID: 28116480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
    Frei AL; McGuigan A; Sinha RRAK; Jabbar F; Gneo L; Tomasevic T; Harkin A; Iveson T; Saunders MP; Oien KA; Maka N; Pezzella F; Campo L; Browne M; Glaire M; Kildal W; Danielsen HE; Hay J; Edwards J; Sansom O; Kelly C; Tomlinson I; Kerr R; Kerr D; Domingo E; ; Church DN; Koelzer VH
    Lancet Oncol; 2024 Feb; 25(2):198-211. PubMed ID: 38301689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of CD4+ and CD8+ tumor-infiltrating lymphocytes in patients with colorectal cancer.
    Tao Y; Xie Y
    Acta Chir Belg; 2024 Feb; 124(1):35-40. PubMed ID: 36780176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXP3+ cell density in lymphoid follicles from histologically normal mucosa is a strong prognostic factor in early stage colon cancer.
    Salama P; Stewart C; Forrest C; Platell C; Iacopetta B
    Cancer Immunol Immunother; 2012 Aug; 61(8):1183-90. PubMed ID: 22210551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of primary tumour location after curative resection in Stage I-III colorectal cancer: a single-centre retrospective study.
    Inoue M; Kanemitsu Y; Tsukamoto S; Moritani K; Takamizawa Y; Daiko H
    Jpn J Clin Oncol; 2024 Mar; ():. PubMed ID: 38535894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer.
    Ladoire S; Martin F; Ghiringhelli F
    Cancer Immunol Immunother; 2011 Jul; 60(7):909-18. PubMed ID: 21644034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women.
    Prizment AE; Vierkant RA; Smyrk TC; Tillmans LS; Nelson HH; Lynch CF; Pengo T; Thibodeau SN; Church TR; Cerhan JR; Anderson KE; Limburg PJ
    Cancer Epidemiol Biomarkers Prev; 2017 Apr; 26(4):622-631. PubMed ID: 27979806
    [No Abstract]   [Full Text] [Related]  

  • 11. Osteoglycin-induced VEGF Inhibition Enhances T Lymphocytes Infiltrating in Colorectal Cancer.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
    EBioMedicine; 2018 Aug; 34():35-45. PubMed ID: 30037719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prognostic score based on B cell and plasma cell densities compared to T cell densities in colorectal cancer.
    Karjalainen H; Sirniö P; Tuomisto A; Mäkinen MJ; Väyrynen JP
    Int J Colorectal Dis; 2023 Feb; 38(1):47. PubMed ID: 36800011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of colorectal cancer patients with bone metastases: a single-center experience.
    Li T; Jing H; Zhang Y; Cao Z; Zhao L; Zhang X; Sun T; Zhang M
    Updates Surg; 2023 Dec; 75(8):2245-2256. PubMed ID: 37976001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of Primary Tumor Sidedness in Stage III Colorectal Cancer: Real-World Evidence from a Brazilian Cohort.
    Protásio BM; de Castria TB; Natalino R; Mangone FR; Saragiotto DF; Sabbaga J; Hoff PM; Chammas R
    Clin Colorectal Cancer; 2024 Mar; 23(1):73-84. PubMed ID: 38151358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.
    Song M; Nishihara R; Wang M; Chan AT; Qian ZR; Inamura K; Zhang X; Ng K; Kim SA; Mima K; Sukawa Y; Nosho K; Fuchs CS; Giovannucci EL; Wu K; Ogino S
    Gut; 2016 Feb; 65(2):296-304. PubMed ID: 25591978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Relevance of Primary Tumor Sidedness in Early-stage Colorectal Cancer: An Integrated Analysis of 4 Randomized Controlled Trials (JCOG2003A).
    Ouchi A; Sadachi R; Hamaguchi T; Tsukamoto S; Shimada Y; Inomata M; Takii Y; Komori K; Shiomi A; Shiozawa M; Ohue M; Watanabe J; Ito M; Kawashima Y; Kobatake T; Souda H; Saida Y; Hashimoto T; Sano Y; Kanemitsu Y;
    Ann Surg; 2024 Feb; 279(2):283-289. PubMed ID: 37551612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients.
    Ling KL; Pratap SE; Bates GJ; Singh B; Mortensen NJ; George BD; Warren BF; Piris J; Roncador G; Fox SB; Banham AH; Cerundolo V
    Cancer Immun; 2007 Mar; 7():7. PubMed ID: 17388261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A basal membrane-like structure surrounding tumour nodules may prevent intraepithelial leucocyte infiltration in colorectal cancer.
    Menon AG; Fleuren GJ; Alphenaar EA; Jonges LE; Janssen van Rhijn CM; Ensink NG; Putter H; Tollenaar RA; van de Velde CJ; Kuppen PJ
    Cancer Immunol Immunother; 2003 Feb; 52(2):121-6. PubMed ID: 12594576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonic epithelial cathelicidin (LL-37) expression intensity is associated with progression of colorectal cancer and presence of CD8
    Porter RJ; Murray GI; Alnabulsi A; Humphries MP; James JA; Salto-Tellez M; Craig SG; Wang JM; Yoshimura T; McLean MH
    J Pathol Clin Res; 2021 Sep; 7(5):495-506. PubMed ID: 33988317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Immunoscore in Colorectal Carcinomas.
    Imen H; Amira H; Fatma K; Raja J; Mariem S; Haithem Z; Ehsene BB; Aschraf C
    Int J Surg Pathol; 2024 Feb; 32(1):58-65. PubMed ID: 37097904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.